Published in Immunology on August 01, 1991
Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation. J Exp Med (1993) 3.31
Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J Exp Med (1992) 2.48
Role of NFkappaB in the mortality of sepsis. J Clin Invest (1997) 2.18
Platelet-activating factor and endotoxin induce tumour necrosis factor gene expression in rat intestine and liver. Immunology (1994) 1.01
Interferon regulatory factor 4 regulates obesity-induced inflammation through regulation of adipose tissue macrophage polarization. Diabetes (2013) 1.00
Agonistic and antagonistic activities of bacterially derived Rhodobacter sphaeroides lipid A: comparison with activities of synthetic material of the proposed structure and analogs. Infect Immun (1995) 1.00
Chloroquine inhibits macrophage tumour necrosis factor-alpha mRNA transcription. Immunology (1993) 0.87
Quantitative proteomic profiling of host-pathogen interactions: the macrophage response to Mycobacterium tuberculosis lipids. J Proteome Res (2009) 0.86
Pathophysiology of sepsis-related cardiac dysfunction: driven by inflammation, energy mismanagement, or both? Curr Heart Fail Rep (2015) 0.84
Interleukin-4 suppression of monocyte tumour necrosis factor-alpha production. Dependence on protein synthesis but not on cyclic AMP production. Immunology (1992) 0.81
LPS-induced production of TNF-α and IL-6 in mast cells is dependent on p38 but independent of TTP. Cell Signal (2013) 0.77
GAPDH Binding to TNF-α mRNA Contributes to Posttranscriptional Repression in Monocytes: A Novel Mechanism of Communication between Inflammation and Metabolism. J Immunol (2016) 0.77
Endotoxin-induced tumor necrosis factor alpha synthesis in murine embryo fibroblasts. Infect Immun (1993) 0.75
Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res (1983) 124.30
Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature (1984) 24.45
Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science (1985) 19.41
Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators. Proc Natl Acad Sci U S A (1986) 15.20
Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature (1988) 13.42
Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science (1986) 9.19
The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med (1989) 6.99
Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors. J Exp Med (1986) 5.09
Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B. Mol Cell Biol (1990) 5.08
Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages. J Exp Med (1990) 4.90
Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia. J Exp Med (1989) 4.66
Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature (1990) 4.46
Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression. J Biol Chem (1988) 4.44
Mouse actin messenger RNAs. Construction and characterization of a recombinant plasmid molecule containing a complementary DNA transcript of mouse alpha-actin mRNA. J Biol Chem (1981) 4.30
Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level. J Exp Med (1990) 4.21
Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog. Surg Gynecol Obstet (1987) 4.18
Translational blockade imposed by cytokine-derived UA-rich sequences. Science (1989) 3.68
Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline. Biochem Biophys Res Commun (1988) 3.63
Phagocytosis and inflammatory stimuli induce GM-CSF mRNA in macrophages through posttranscriptional regulation. Cell (1987) 3.46
Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist. J Clin Invest (1990) 2.83
Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway. J Exp Med (1990) 2.79
Analysis of interferon mRNA in human fibroblast cells induced to produce interferon. Proc Natl Acad Sci U S A (1981) 2.77
Production of interleukin-1 but not tumor necrosis factor by human monocytes stimulated with pneumococcal cell surface components. Infect Immun (1989) 2.31
Transcriptional and posttranscriptional regulation of tumor necrosis factor gene expression in human monocytes. J Clin Invest (1988) 2.29
Differential regulation of lipopolysaccharide-induced interleukin 1 and tumor necrosis factor synthesis: effects of endogenous and exogenous glucocorticoids and the role of the pituitary-adrenal axis. Eur J Immunol (1989) 1.93
Two interleukin 1 genes in the mouse: cloning and expression of the cDNA for murine interleukin 1 beta. J Immunol (1986) 1.87
The AU-rich sequences in the 3' untranslated region mediate the increased turnover of interferon mRNA induced by glucocorticoids. J Exp Med (1991) 1.84
Genomic sequence for human prointerleukin 1 beta: possible evolution from a reverse transcribed prointerleukin 1 alpha gene. Nucleic Acids Res (1986) 1.66
Synergistic activation of human monocytes by granulocyte-macrophage colony-stimulating factor and IFN-gamma. Increased TNF-alpha but not IL-1 activity. J Immunol (1988) 1.65
Genetic analysis of the human tumor necrosis factor alpha/cachectin promoter region in a macrophage cell line. J Exp Med (1989) 1.62
Differential inhibition of IL-1 and TNF-alpha mRNA expression by agents which block second messenger pathways in murine macrophages. J Immunol (1988) 1.55
Transcriptional regulation of the human prointerleukin 1 beta gene. J Immunol (1987) 1.54
Dissociation between interleukin-1 beta mRNA and protein synthesis in human peripheral blood mononuclear cells. J Biol Chem (1990) 1.53
Interleukin 1 receptor blockade attenuates the host inflammatory response. Proc Natl Acad Sci U S A (1990) 1.47
Regulation of tumour necrosis factor production by mouse peritoneal macrophages: the role of cellular cyclic AMP. Immunology (1988) 1.42
Regulation of monokine gene expression: prostaglandin E2 suppresses tumor necrosis factor but not interleukin-1 alpha or beta-mRNA and cell-associated bioactivity. J Leukoc Biol (1989) 1.30
Regulation of serum tumor necrosis factor in glucocorticoid-sensitive and -resistant rodent endotoxin shock models. Infect Immun (1989) 1.26
Mouse lymphotoxin and tumor necrosis factor: structural analysis of the cloned genes, physical linkage, and chromosomal position. J Immunol (1987) 1.21
Dynamics of dibutyryl cyclic AMP- and prostaglandin E2-mediated suppression of lipopolysaccharide-induced tumor necrosis factor alpha gene expression. Infect Immun (1989) 1.17
Regulation of expression of human IL-1 alpha and IL-1 beta genes. J Immunol (1989) 1.10
Modulation of tumor necrosis factor-alpha gene expression. Desensitization of prostaglandin E2-induced suppression. J Immunol (1989) 1.05
Interleukin 1 in rheumatoid arthritis: potentiation of immune responses within the joint. Lymphokine Res (1989) 0.98
Gene regulation in macrophage activation: differential regulation of genes encoding for tumor necrosis factor, interleukin-1, JE, and KC by interferon-gamma and lipopolysaccharide. J Leukoc Biol (1990) 0.98
Regulation of tumor necrosis factor gene expression and protein synthesis in murine macrophages treated with recombinant tumor necrosis factor. J Immunol (1990) 0.93
Coordinated induction of autocrine tumor necrosis factor and interleukin 1 in normal human monocytes and the implications for monocyte-mediated cytotoxicity. Cancer Res (1990) 0.90
Pharmacologic modulation of TNF production by endotoxin stimulated macrophages: in vitro and in vivo effects of auranofin and other chrysotherapeutic compounds. Agents Actions (1989) 0.85
Differential effects of apoptotic versus lysed cells on macrophage production of cytokines: role of proteases. J Immunol (2001) 2.22
MRI vs. histologic measurement of breast cancer following chemotherapy: comparison with x-ray mammography and palpation. J Magn Reson Imaging (2001) 1.51
Inhibition of glycinamide ribonucleotide formyltransferase results in selective inhibition of macrophage cytokine secretion in vitro and in vivo efficacy in rat adjuvant arthritis. Clin Exp Rheumatol (2005) 1.38
Endotoxin-macrophage interaction: post-translational regulation of tumor necrosis factor expression. J Immunol (1989) 1.32
Endotoxin tolerance: independent regulation of interleukin-1 and tumor necrosis factor expression. Infect Immun (1991) 1.24
Mammographic appearances of male breast disease. Radiographics (1999) 1.20
The relationships between personal PM exposures for elderly populations and indoor and outdoor concentrations for three retirement center scenarios. J Expo Anal Environ Epidemiol (2001) 1.19
Transcriptional inhibition of endotoxin-induced monokine synthesis following heat shock in murine peritoneal macrophages. J Leukoc Biol (1992) 1.12
Endotoxin tolerance: in vivo regulation of tumor necrosis factor and interleukin-1 synthesis is at the transcriptional level. Cell Immunol (1992) 1.08
The Lady Sedley's Receipt Book, 1686, and other Seventeenth Century Receipt Books. Proc R Soc Med (1913) 1.04
Neuroendocrine regulation of in vivo cytokine production and effects: I. In vivo regulatory networks involving the neuroendocrine system, interleukin-1 and tumor necrosis factor-alpha. J Neuroimmunol (1989) 1.02
In vivo modulation of murine serum tumour necrosis factor and interleukin-6 levels during endotoxemia by oestrogen agonists and antagonists. Immunology (1995) 0.91
Cytokine regulation of macrophage apo E secretion: opposing effects of GM-CSF and TGF-beta. Atherosclerosis (1992) 0.89
Dielectric properties of the system bovine albumin: urea: betaine in aqueous solution. Phys Med Biol (1992) 0.85
The effect of a selective estrogen receptor modulator on the progression of spontaneous autoimmune disease in MRL lpr/lpr mice. Cell Immunol (1996) 0.84
Evaluation of a new free-thyroxin assay. Clin Chem (1981) 0.81
Endotoxin and GM-CSF-mediated down-regulation of macrophage apo E secretion is inhibited by a TNF-specific monoclonal antibody. J Leukoc Biol (1994) 0.80
Exogenous glucocorticoids increase macrophage secretion of apo E by cholesterol-independent pathways. Atherosclerosis (1993) 0.80
Estriol: a potent regulator of TNF and IL-6 expression in a murine model of endotoxemia. Inflammation (1996) 0.78
DNA repair inhibition: a new mechanism of action of steroids with possible implications for tumor therapy. Proc Soc Exp Biol Med (1974) 0.77
Cholesteryl ester transfer protein inhibition in hypercholesterolemic hamsters: kinetics of apoprotein changes. Lipids (1995) 0.77
Estrogen-mediated increases in LDL cholesterol and foam cell-containing lesions in human ApoB100xCETP transgenic mice. Arterioscler Thromb Vasc Biol (1999) 0.76
Arteritis obliterans of Right Upper Extremity associated with Malformation of both Clavicles. Proc R Soc Med (1908) 0.76
Chronic administration of dexamethasone results in Fc receptor up-regulation and inhibition of class I antigen expression on macrophages from MRL/lpr autoimmune mice. Clin Diagn Lab Immunol (1997) 0.75
Muscular Atrophy and other Changes in Nutrition associated with Lesions of the Sensory Cortex of the Brain, with Especial Reference to the Possible Existence of Trophic Representation in the Post-central Areas. Proc R Soc Med (1918) 0.75
Interactions of recombinant hemoglobin (rHb1.1) and endotoxin in vivo: effects on systemic tumor necrosis factor and interleukin-6 levels in lethal and sublethal murine models of endotoxemia. J Lab Clin Med (1997) 0.75
Congenital Insufficiency of Soft Palate. Proc R Soc Med (1911) 0.75
In vivo dexamethasone effects on neutrophil effector functions in a rat model of acute lung injury. Inflammation (1997) 0.75
Whooping-cough. A Discussion. Proc R Soc Med (1909) 0.75
Case of Family Splenomegalic Acholuric Jaundice. Proc R Soc Med (1917) 0.75
Montana state university: an employee wellness program financed by a self-insurance group health plan. Am J Health Promot (1989) 0.75
Thyroxine binding globulin in PNG natives. Med J Aust (1982) 0.75
Chronic Jaundice and Splenomegaly. Proc R Soc Med (1912) 0.75
Functional Trismus. Proc R Soc Med (1908) 0.75
Transposition of Viscera in a Girl, aged 12 Years. Proc R Soc Med (1912) 0.75
Amyotrophic Lateral Sclerosis in a Man, aged 28, showing Chvostek's Sign. Proc R Soc Med (1916) 0.75
Case of Polio-encephalo-myelitis. Proc R Soc Med (1916) 0.75
Tumour of Right Cerebello-pontine Angle; Posterior Decompression in May, 1914; Great Improvement. Proc R Soc Med (1915) 0.75
Helminthiasis in West Virginia. W V Med J (1967) 0.75
The Texas Natural Death Act. Tex Med (1988) 0.75
Expression of CD54 (intercellular adhesion molecule-1) and the beta 1 integrin CD29 is modulated by a cyclic AMP dependent pathway in activated primary rat microglial cell cultures. Inflammation (1998) 0.75
Syphilis Meningo-vascularis, Congenital Syphilis, Choroiditis, Optic Atrophy, Herpes Zoster, Multiple Root Lesions. Proc R Soc Med (1915) 0.75
Case of Ascites of Obscure Origin. Proc R Soc Med (1917) 0.75
Congenital Insufficiency of Ocular and Facial Movements. Proc R Soc Med (1914) 0.75
? Kernikterus associated with Choreiform Movements. Proc R Soc Med (1914) 0.75
Epidemic Catarrhal Jaundice. Proc R Soc Med (1913) 0.75
Congenital Cerebellar Ataxy. Proc R Soc Med (1909) 0.75
Cerebral Diplegia (non-congenital) in Children. Proc R Soc Med (1908) 0.75
Congenital Cerebellar Ataxy. Proc R Soc Med (1913) 0.75
Two Cases of Transitory Diabetes Insipidus. Proc R Soc Med (1914) 0.75
Two Cases of Muscular Atrophy of the Peroneal Type (Charcot, Marie, Tooth) in Father and Son. Proc R Soc Med (1911) 0.75
A Discussion on "Tics.". Proc R Soc Med (1908) 0.75